Skip to Main Content

Paper Details

One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion.
Clin Exp Ophthalmol
4
2022
Author NameAffiliation
Vuong NguyenClinical Ophthalmology & Eye Health, University of Sydney
Ian L McAllisterLions Eye Institute, University of Western Australia
Daniel BarthelmesUniversity Hospital of Zurich
Mark C GilliesUniversity of Sydney, Sydney Medical School, Save Sight Institute
  • 1 - 4

Datasets

Release 1.2